Biohaven
BHVN
187 hedge funds and large institutions have $1.44B invested in Biohaven in 2023 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 65 reducing their positions, and 24 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
58% more capital invested
Capital invested by funds: $910M → $1.44B (+$532M)
50% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 24
6% more funds holding
Funds holding: 176 → 187 (+11)
8.99% less ownership
Funds ownership: 97.56% → 88.57% (-9%)
12% less call options, than puts
Call options by funds: $22.4M | Put options by funds: $25.6M
26% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.16M |
| 2 |
BW
Bison Wealth
Atlanta,
Georgia
|
+$6.22M |
| 3 |
Goldman Sachs
New York
|
+$5.91M |
| 4 |
PA
Perceptive Advisors
New York
|
+$5.52M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$28.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26.7M |
| 3 |
AC
Armistice Capital
New York
|
-$22.8M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9.92M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$9.56M |
BHVN Hedge Fund Activity: Q2 2023 in Review
187 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q2 2023, worth a combined $1.44B — up 58% from $910M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new BHVN positions and 24 closed out — a net gain of 12 holders — while 48 added to existing stakes and 65 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $9.16M. The largest seller was State Street, cutting an estimated $28.9M.
- 187 institutional investors held Biohaven (BHVN) as of Q2 2023, up from 176 in Q1 2023.
- Funds reported $1.44B of Biohaven stock for Q2 2023, up 58% quarter-over-quarter.
- 36 funds opened new Biohaven positions in Q2 2023 and 24 closed out, a net change of +12 holders.
- The largest Biohaven buyer in Q2 2023 was T. Rowe Price Associates, an estimated $9.16M added.
- The largest Biohaven seller in Q2 2023 was State Street, an estimated $28.9M sold.
Based on aggregated 13F filings for Q2 2023.